Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From 3M
Solventum: The Identity Of 3M’s Health Care Spin-Off
3M’s health care company spin-off is expected to be launched in the first half of 2024 under the name Solventum.
News We’re Watching: Boston Scientific Closes Relievant, Medtronic's PFA Earns CE Mark, And More
Medtech Insight's News We're Watching highlights medtech industry news developments you may have missed over the last few weeks.
November US FDA User Fee Calendar: Takeda On Tap; Small Molecules For Cancer
Takeda hopes for good news on fruquintinib and TAK-755, while Bristol and SpringWorks share a goal date for their breakthrough-designated cancer treatments.
Breakthrough Bounceback Looks Unlikely At US FDA’s CDER, But CBER Is Riding Wave Of RMATs
Only two breakthrough-designated novel agents remain on the US FDA drugs center’s 2023 user fee calendar, while CBER stacks up on vaccines and gene therapies under both BTD and RMAT programs.
Company Information
- Industry
- Biotechnology
- Medical Devices
- Pharmaceuticals
-
Pharmaceuticals
- OTC, Consumer
-
Medical Devices
- Consumables, Central Supplies
-
Diagnostic Imaging Equipment & Supplies
- X-ray
-
Digital Health
- Artificial Intelligence
- Other Names / Subsidiaries
-
- 3M Company
- Acelity L.P. Inc.
- Crawford Healthcare Holdings Limited
- Kinetic Concepts, Inc.
- M*Modal
- Minnesota Mining and Manufacturing
- Scott Safety
- Semfinder
- Systagenix Wound Management, Limited
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice